Trivant Custom Portfolio Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Trivant Custom Portfolio Group's MRK Position: Q2 2025 in Review
Trivant Custom Portfolio Group sold out of Merck (MRK) in Q2 2025, closing a stake of 19,639 shares — an estimated $1.76M sold.
Trivant Custom Portfolio Group first reported a position in MRK in Q1 2023 and held it in 9 quarters. The position peaked at $4.38M in Q1 2024. 3,327 funds tracked by Wall St. Rank hold MRK as of Q2 2025.
- Trivant Custom Portfolio Group reported no remaining Merck position as of Q2 2025 after selling out during the quarter.
- Trivant Custom Portfolio Group sold 19,639 Merck shares in Q2 2025, an estimated $1.76M.
- Trivant Custom Portfolio Group first reported a position in Merck in Q1 2023 and held it in 9 quarters.
- Trivant Custom Portfolio Group's Merck position peaked at $4.38M in Q1 2024.
- 3,327 funds tracked by Wall St. Rank held Merck as of Q2 2025.
Based on Trivant Custom Portfolio Group's 13F filing for Q2 2025, filed 12 Aug 2025.